Official Title
Thromboembolic Complications Post-COVID-19: What is the Risk in Mild-Moderate Cases?
Brief Summary

The aim of the study is to investigate the frequency of thromboembolic complications andthe factors influencing them in COVID-19 cases that did not require hospitalization. Forthis purpose, patients registered at two different family health centers in Istanbul wereretrospectively screened, and their status regarding post-COVID-19 thromboembolic eventswas recorded. The sociodemographic characteristics, medical history, COVID-19 treatmentsreceived, comorbidities, and current medications of all patients were examined andcompared with the occurrence of complications.

Detailed Description

Studies on COVID-19 complications in the literature have predominantly focused on
patients treated in hospitals, particularly in intensive care units. Data on patients
with mild to moderate symptoms who were followed up on an outpatient basis in primary
care are quite limited. Therefore, our research investigated the incidence of thrombotic
events within six months following infection in mild to moderate COVID-19 cases and the
factors that might influence these events. Records of 961 individuals registered at two
different family health centers in Istanbul were reviewed. Patients were contacted by
phone, informed about the study, and data regarding their sociodemographic
characteristics, medical histories, COVID-19 infection experiences, and medications used
were collected. Comparative analyses (Fisher's exact test) and logistic regression tests
were conducted.

Completed
COVID 19
Thromboembolic and Bleeding Complications
Thromboembolism, Venous
Post COVID-19
Eligibility Criteria

Inclusion Criteria:

- Being over 18 years of age

- Having had a confirmed COVID-19 infection verified by a PCR test

- Being monitored at a family health center without requiring hospitalization during
the COVID-19 course

- Having at least 6 months elapsed since the infection

- Availability of the patient's medical records

- Absence of any language barrier or health issue that would prevent communication
with the patient

Exclusion Criteria:

- Being under 18 years of age

- Having had less than 6 months since the COVID-19 infection

- Presence of any condition that prevents communication with the patient

- Incomplete or missing medical records of the patient

- History of hospitalization due to COVID-19 infection

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Turkey (Türkiye)
Locations

Marmara University Medical School
Istanbul 745044, Turkey (Türkiye)

Buğu Usanma Koban, Principal Investigator
Marmara University Medical Faculty

Marmara University Pendik Training and Research Hospital
NCT Number
Keywords
COVID 19
Thromboembolism
thromboembolic complications
Pulmonary Embolism
Deep Venous Thrombosis
MeSH Terms
COVID-19
Venous Thromboembolism
Thromboembolism
Pulmonary Embolism
Venous Thrombosis